Skip to main content
Ocugen, Inc. logo

Ocugen, Inc. — Investor Relations & Filings

Ticker · OCGN ISIN · US43358V1098 LEI · 549300JVNUI9CXWJLR09 US Manufacturing
Open in API
Filings indexed 848 across all filing types
Latest filing 2019-04-08 M&A Activity
Country US United States of America
Listing US OCGN

About Ocugen, Inc.

https://ocugen.com/

Ocugen, Inc. is a clinical-stage biotechnology company focused on discovering, developing, and commercializing novel gene therapies, cell therapies, and vaccines. The company's primary mission is to develop treatments for blindness diseases, leveraging its first-in-class modifier gene therapy platform. This platform represents a potential paradigm shift in treating inherited retinal diseases by aiming to address multiple genetic mutations with a single product. In addition to its focus on ocular health, Ocugen is also advancing a pipeline that includes vaccines for infectious diseases. The company is dedicated to addressing significant unmet medical needs and providing innovative therapeutic options for patients with debilitating conditions.

Recent filings

Filing Released Lang Actions
8-K
M&A Activity Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated April 8, 2019, reporting a material definitive agreement regarding a merger between Histogenics Corporation and Ocugen, Inc. The text includes detailed descriptions of the merger agreement, voting agreements, lock-up agreements, and the expected changes in board composition and company name. It also references the upcoming filing of a Form S-4 registration statement containing a proxy statement and prospectus related to the merger. The document is a current report disclosing a significant corporate transaction (merger agreement) and related agreements, which fits the category of M&A Activity filings. It is not a full merger proxy statement or tender offer filing (which would be under MA), but rather an 8-K announcement of the merger agreement and related arrangements. Therefore, the appropriate classification is M&A Activity (TAR). The document length (15,000 characters) and content confirm it is a substantive announcement, not a brief notice or certification.
2019-04-08 English
425 Filing
Regulatory Filings
2019-04-08 English
425 Filing
Regulatory Filings
2019-04-08 English
10-K
Annual Report FY 2018
2019-03-21 English
8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content focuses on a restructuring plan, including workforce reductions and the departure of key officers (CEO and COO), along with details of their separation agreements and severance arrangements. There is no financial statement or detailed financial performance data presented, nor is this a full annual or quarterly report. The primary subject is the departure of officers and related compensatory arrangements, which aligns with announcements about changes in senior management or the board. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length and detail support a high confidence in this classification.
2019-03-15 English
8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated March 5, 2019, reporting a change in the company's board of directors and committee appointments. The key content is the resignation of a director and subsequent board committee changes. There are no financial statements or detailed financial data presented. The document is focused on management and board changes, which aligns with the category for announcements of changes in the company's board or senior management. Therefore, the appropriate classification is 'Board/Management Information' (MANG). The document length is 3669 characters, which is typical for such announcements and not a full report or earnings release.
2019-03-05 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.